No clinically relevant hypersensitivity reactions in clinical trials with tralokinumab in asthma
Sign Up to like & getrecommendations! Published in 2018 at "European Respiratory Journal"
DOI: 10.1183/13993003.congress-2018.pa1034
Abstract: Introduction: Anaphylaxis and severe hypersensitivity reactions are a concern for any biologic substance. The anti-IL-13 agent tralokinumab is produced by a murine cell line and may thus incorporate immunogenic α-Gal epitopes in the Fab domain.… read more here.
Keywords: clinical studies; severe hypersensitivity; gal epitopes; hypersensitivity reactions ... See more keywords
Health-related quality of life in severe hypersensitivity reactions: focus on severe allergic asthma and hymenoptera venom anaphylaxis—a cross-sectional study
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Psychology"
DOI: 10.3389/fpsyg.2024.1394954
Abstract: Background Growing evidence reveals the important role of clinical psychological factors in chronic-immune diseases. The aim of this study was to investigate Health-Related Quality of Life (HR-QoL), depression, anxiety, and alexithymia in patients with severe… read more here.
Keywords: related quality; health related; quality life; clinical psychological ... See more keywords